Trump’s win could rock the FDA, experts wary of RFK Jr.’s role

With Donald Trump’s victory in the presidential election, public health experts are eagerly awaiting to see whether his embrace of Robert F. Kennedy Jr. will translate into real policy, and perhaps chaos, at the Food and Drug Administration – the regulator charged with ensuring that America’s medicines are effective and food is safe to eat.

In the weeks leading up to the election, Trump promised his supporters that he would kill RFK Jr. an important role in his government and would give him the opportunity “go wild” on healthcare.

In his victory speech, the President-elect mentioned Kennedy again. “He’s going to help make America healthy again,” Trump said. “He’s a great guy and he really means it. He wants to do some things, and we let him go there.

STAT+ Exclusive story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article – plus daily information about Capitol Hill and the life sciences industry – by subscribing to STAT+.

Do you already have an account? Login

Individual plans

Group plans

View all subscriptions

Subscribe to STAT+ to read the rest of this story.

Subscribe